November 10, 2007
Epogen, Aranesp, and Procrit Get Stronger Warnings
Posted at November 10, 2007 9:51 AM in .
Two pharmaceutical companies, Johnson & Johnson and Amgen, have agreed to place stronger warning labels on three anemia drugs. The decision was made in consulation with the FDA after studies have shown that Epogen, Aranesp, and Procrit all could cause heart attacks, a worsening of cancer, and death. The drugs are used by approximately 1 million cancer patients a year.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/439 .